Clinical Trials on 第 2 期部分:小细胞肺癌 (SCLC) in Korea, Republic of
总计734个结果
-
GlaxoSmithKline完全的
-
Yonsei University撤销
-
Samyang Biopharmaceuticals Corporation完全的
-
NKMAX Co., Ltd.招聘中
-
Samsung Medical CenterCytoGen, Inc.; UNIST (Ulsan National Institute of Science and Technology)主动,不招人NSCLC IV期 | 非小细胞肺癌 IIIB 期大韩民国
-
National Cancer Center, KoreaBoehringer Ingelheim完全的
-
Samsung Medical Center终止
-
Samsung Medical CenterAstraZeneca终止
-
Seoul National University HospitalAstraZeneca; Korean Cancer Study Group完全的
-
Chonnam National University HospitalChong Kun Dang Pharmaceutical完全的
-
National Cancer Center, KoreaSamsung Medical Center; Asan Medical Center; Seoul National University Hospital; Seoul National...主动,不招人
-
National Cancer Center, KoreaRoche Korea co.,Ltd.主动,不招人
-
Chong Kun Dang PharmaceuticalSamsung Medical Center; Asan Medical Center; Seoul National University Hospital招聘中
-
Seoul National University Hospital完全的
-
Samsung Medical Center尚未招聘
-
Sung Yong LeeYuhan Corporation招聘中非小细胞肺癌 III 期 | 非鳞状非小细胞肺癌 | EGFR阳性非小细胞肺癌大韩民国
-
Samsung Medical Center完全的
-
Samsung Medical Center完全的
-
Yonsei University招聘中
-
Yonsei University未知具有常见 EGFR 突变的完全切除的 NSCLC大韩民国
-
National Cancer Center, KoreaRoche Korea co.,Ltd.招聘中
-
National Cancer Center, KoreaPfizer; Roche Pharma AG未知
-
JI-YOUN HANSeoul National University Hospital; Seoul National University Bundang Hospital; Severance Hospital主动,不招人
-
Clinical Research Center for Solid Tumor, KoreaSeoul National University Hospital; Korean Cancer Study Group终止
-
Yonsei University未知